Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.
Foresight Diagnostics has raised $33.0M in total funding. The most recent round was Series B. The last funding was announced in July 2024.
Foresight Diagnostics's investors include Pear VC, Civilization Ventures, Agent Capital, Foresite Capital, Stanford University.
Foresight Diagnostics is headquartered in Denver, United States.
Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.
Foresight Diagnostics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Foresight Diagnostics — Funding & Investors." VCBacked, July 30, 2024, https://www.vcbacked.co/company/foresight-diagnostics. Accessed October 29, 2026.
VCBacked. (2024). Foresight Diagnostics — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/foresight-diagnostics
{{cite web |title=Foresight Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/foresight-diagnostics |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated